Treatment of Nasal Cavity Cancer in Malignant Melanoma or Sarcoma

Malignant melanoma and sarcoma of the nasal cavity represent a rare and histologically distinct subset of nasal cavity tumours. Their biological behaviour and management differ substantially from the more common epithelial malignancies arising at this site, requiring a histology-specific approach.

Clinical scenario

The primary histology is malignant melanoma or sarcoma of the nasal cavity. Malignant melanoma accounts for less than 1% of neoplasms in this region, and — together with lymphomas and sarcomas — these tumour types are not staged through the standard nasal cavity staging system. Their rarity and distinct biology place them in a separate management pathway.

Treatment approach (partial overview)

When disease characteristics allow, surgical intervention forms a central part of the approach. Beyond surgery, the systemic component is tailored specifically to the tumour's cell type rather than following a single fixed regimen. The full sequence of options, criteria for each, and specific recommendations are detailed in the complete protocol →

Instant Access to Structured Evidence-Based Regimens

References

Malignant melanoma presents in less than 1% of neoplasms in this region.
Lymphomas, sarcomas, and mucosal melanomas of the paranasal sinuses and nasal cavity are not staged using this system.
Surgical excision if possible.
Appropriate chemotherapy geared specifically to cell type.

View source ↗